# Carbetocin Versus Buccal Misoprostol Plus IV Tranexamic Acid for Prevention of Postpartum Hemorrhage at Cesarean Section

> **NCT03710317** · NA · COMPLETED · sponsor: **Aswan University Hospital** · enrollment: 400 (actual)

## Conditions studied

- Cesarean Section Complications

## Interventions

- **DRUG:** carbetocin
- **DRUG:** Tranexamic Acid
- **DRUG:** misoprostol

## Key facts

- **NCT ID:** NCT03710317
- **Lead sponsor:** Aswan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-01
- **Primary completion:** 2020-05-30
- **Final completion:** 2020-08-01
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2020-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03710317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03710317, "Carbetocin Versus Buccal Misoprostol Plus IV Tranexamic Acid for Prevention of Postpartum Hemorrhage at Cesarean Section". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03710317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*